These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 36810560)
1. Epigenetic Regulation in Breast Cancer: Insights on Epidrugs. Kim A; Mo K; Kwon H; Choe S; Park M; Kwak W; Yoon H Epigenomes; 2023 Feb; 7(1):. PubMed ID: 36810560 [TBL] [Abstract][Full Text] [Related]
2. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. Bouyahya A; Mechchate H; Oumeslakht L; Zeouk I; Aboulaghras S; Balahbib A; Zengin G; Kamal MA; Gallo M; Montesano D; El Omari N Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327559 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic Therapies in Triple-Negative Breast Cancer: Concepts, Visions, and Challenges. Lehmann U Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927870 [TBL] [Abstract][Full Text] [Related]
4. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer. Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383 [TBL] [Abstract][Full Text] [Related]
5. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer. Oh S; Ko JY; Oh C; Yoo KH Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690 [TBL] [Abstract][Full Text] [Related]
6. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation. Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908 [TBL] [Abstract][Full Text] [Related]
7. Epidrugs: targeting epigenetic marks in cancer treatment. Miranda Furtado CL; Dos Santos Luciano MC; Silva Santos RD; Furtado GP; Moraes MO; Pessoa C Epigenetics; 2019 Dec; 14(12):1164-1176. PubMed ID: 31282279 [TBL] [Abstract][Full Text] [Related]
8. [Targeted epigenetic therapy of cancer. Achievements and perspectives]. Valdespino-Gómez VM; Valdespino-Castillo VE Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455 [TBL] [Abstract][Full Text] [Related]
9. Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy. Myasoedova VA; Sukhorukov V; Grechko AV; Zhang D; Romanenko E; Orekhov V; Orekhov AN Curr Pharm Des; 2019; 25(6):635-641. PubMed ID: 30950345 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes. Peixoto P; Grandvallet C; Feugeas JP; Guittaut M; Hervouet E Cells; 2019 Dec; 8(12):. PubMed ID: 31861179 [TBL] [Abstract][Full Text] [Related]
11. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target]. Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229 [TBL] [Abstract][Full Text] [Related]
12. Anticancer mechanisms of phytochemical compounds: focusing on epigenetic targets. El Omari N; Bakha M; Imtara H; Guaouguaoua FE; Balahbib A; Zengin G; Bouyahya A Environ Sci Pollut Res Int; 2021 Sep; 28(35):47869-47903. PubMed ID: 34308524 [TBL] [Abstract][Full Text] [Related]
13. Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy. Montalvo-Casimiro M; González-Barrios R; Meraz-Rodriguez MA; Juárez-González VT; Arriaga-Canon C; Herrera LA Front Oncol; 2020; 10():605386. PubMed ID: 33312959 [TBL] [Abstract][Full Text] [Related]
14. Epigenetics as a therapeutic target in breast cancer. Connolly R; Stearns V J Mammary Gland Biol Neoplasia; 2012 Dec; 17(3-4):191-204. PubMed ID: 22836913 [TBL] [Abstract][Full Text] [Related]
15. Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. Feng J; Meng X Front Pharmacol; 2022; 13():946811. PubMed ID: 36188615 [TBL] [Abstract][Full Text] [Related]
16. HDAC modulation and cell death in the clinic. Dell'Aversana C; Lepore I; Altucci L Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671 [TBL] [Abstract][Full Text] [Related]
17. Modulating epigenetic modifications for cancer therapy (Review). Castro-Muñoz LJ; Ulloa EV; Sahlgren C; Lizano M; De La Cruz-Hernández E; Contreras-Paredes A Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799181 [TBL] [Abstract][Full Text] [Related]
18. Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development. Jin Y; Liu T; Luo H; Liu Y; Liu D Front Oncol; 2022; 12():848221. PubMed ID: 35419278 [TBL] [Abstract][Full Text] [Related]